A panel of scientists says a proposed federal limit of 24.5 parts per billion on the toxic chemical perchlorate in drinking water is too high.
The federal advisory panel said the U.S. Environmental Protection Agency's health goal for the chemical that has contaminated drinking water and foods across the nation poses neurodevelopmental risks for babies, The Los Angeles Times reported Thursday. Most of the perchlorate contamination occurs near military bases or aerospace facilities.
The scientists say the proposed limit for perchlorate, an ingredient of solid rocket fuel, "is not supported by the underlying science and can result in exposures that pose neurodevelopmental risks in early life," wrote Melanie Marty of California's Office of Environmental Health Hazard Assessment, chairwoman of the EPA's Children's Health Protection Advisory Committee.
Another EPA scientific advisory panel this year criticized the Bush administration for proposing a standard for another pollutant, saying it would not adequately protect public health, the Times said.
In contrast, California recently proposed a goal of 6 ppb, and this week Massachusetts officials proposed a standard of 2 ppb for perchlorate.
Copyright 2006 by United Press International
Related stories:
Science paper examines role of aerosols in climate change
A group of scientists affiliated with the International Geosphere-Biosphere Programme (IGBP) have proposed a new framework to account more accurately for the effects of aerosols on precipitation in climate models. Their work appears in the 5 September issue of
Science magazine.
Study: Workers to pay more for health care
(AP) -- Get ready for another hike in copays and deductibles. A survey being released Thursday by the Mercer consulting firm found 59 percent of companies intend to keep down rising health care costs in 2009 by raising workers' deductibles, copays or out-of-pocket spending limits.
25 years of conventional evaluation of data analysis proves worthless in practice
So-called 'intelligent' computer-based methods for classifying patient samples, for example, have been evaluated with the help of two methods that have completely dominated research for 25 years. Now Swedish researchers at Uppsala University are revealing that this methodology is worthless when it comes to practical problems. The article is published in the journal
Pattern Recognition Letters.
Watch out for drug names that look, sound alike
(AP) -- Take the generic drug clonidine for high blood pressure? Double-check that you didn't leave the drugstore with Klonopin for seizures, or the gout medicine colchicine.
Why Strawberry Jam is More Regulated than Cigarettes
(PhysOrg.com) -- While jams and other consumer products are strictly regulated and are required to pass stringent tests before they can be sold, tobacco has no restrictions and manufacturers can, and do, add anything they want into the product.
Study outcome won't sway company on eye drug
(AP) -- What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000? In the case of Genentech Inc., nothing.
Unusual ultrasonic vocalization patterns in mice may be useful for modeling autism
Scientists have found novel patterns of ultrasonic vocalizations in a genetic mouse model of autism, adding a unique element to the available mouse behaviors that capture components of the human disease, and representing a new step towards identifying causes and better treatments.
Rifamycin antibiotics attack tuberculosis bacteria with walls, not signals
(PhysOrg.com) -- Amid concerns about the rising number of new tuberculosis cases worldwide, researchers led by Rockefeller University’s Seth A. Darst have reexamined and disproved a theory that describes how a potent class of antibiotics kills a deadly form of bacteria. The findings, which will appear in this week’s online issue of the
Proceedings of the National Academy of Sciences, not only bring scientists closer to understanding how these antibiotics work but also how the bacteria become resistant to their effects.